Urinary Tract Infection Clinical Trial
Official title:
ORWH:SCOR - Sex/Gender Factors Affecting Women's Health
This project is the clinical project of a Specialized Center of Research (SCOR) proposal
which is designed to further our understanding of urinary tract infection (UTI) in women.
Acute uncomplicated urinary tract infections (UTIs) occur in an estimated 7-11 million women
each year, and the annual costs of caring for these women are thought to approach $1.6
billion. Approximately 20-30% of women suffer from frequent recurrent infections. UTIs in
young women result in substantial symptoms, time lost from work, and medical costs. An
improved understanding of the mechanisms underlying UTIs could result in new approaches to
their prevention and reduced numbers of women with infections and the amount of antibiotics
use.
In this project we seek a better understanding of the causes of UTI. Most experts believe
that vaginal colonization with UTI-causing bacteria from the rectal flora precedes
colonization of the urethra (the tube from the bladder for urination) and bladder and
subsequent UTI, but the relationships between these events has not been established.
Moreover, recent information from studies in mice strongly suggest that persistent bladder
infection follows an initial bladder infection.
In this project, we will prospectively follow a large group of women with recurrent UTI to
determine: 1) the relationships in time between vaginal colonization with a UTI-causing
bacteriuria, asymptomatic bacteriuria (bacteria in the bladder but without any UTI symptoms)
and symptomatic UTI, and 2) the presence of persistent bacteria in the bladder following the
symptomatic UTI at entry into the study and whether such bacteria are related to later UTIs
that are caused by the same bacteria that caused the UTI at entry into the study. We will
thus be able to determine the relative importance of vaginal colonization vs. persistent
infection of the bladder as the origin of the bacteria causing recurrent UTI.
UTI-causing bacteria cultured from women with symptomatic UTI and asymptomatic bacteriuria
will undergo studies by Dr. Scott Hultgren's group at Washington University in Project 1 to
identify unique genes that may help us understand why some bacteria cause symptoms and
others do not. The effect of bacteria causing UTI in these women on host response will also
be determined by studies by Dr. Jeff Gordon's laboratory at Washington University in Project
3.
A better understanding of the molecular and epidemiologic basis of UTI is critical in
developing the best possible prevention and management strategies.
n/a
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03235947 -
Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients
|
Phase 4 | |
Terminated |
NCT02198833 -
Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection
|
N/A | |
Withdrawn |
NCT01881165 -
Cranberry on Urinary Tract Infections
|
Phase 4 | |
Completed |
NCT02357758 -
Effects of Antibiotic Prophylaxis on Recurrent UTI in Children
|
Phase 4 | |
Completed |
NCT01687114 -
Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products
|
N/A | |
Completed |
NCT01391793 -
Corticosteroids for Children With Febrile Urinary Tract Infections
|
Phase 3 | |
Completed |
NCT01219595 -
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
|
N/A | |
Completed |
NCT00365430 -
SAFE or SORRY? Patient Safety Study of the Prevention of Adverse Patient Outcomes
|
N/A | |
Recruiting |
NCT04502095 -
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
|
Phase 4 | |
Completed |
NCT00976963 -
Single Dose Monurol for Treatment of Acute Cystitis
|
N/A | |
Recruiting |
NCT02568800 -
Prolonged Infusion Cefepime and Nosocomial Infections
|
Phase 3 | |
Completed |
NCT02785445 -
Healthy.io Method Comparison & User Performance Study
|
N/A | |
Completed |
NCT02216253 -
L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.
|
N/A | |
Completed |
NCT01478620 -
Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)
|
Phase 3 | |
Completed |
NCT01054690 -
Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)
|
N/A | |
Completed |
NCT00371631 -
Colonizing Neurogenic Bladders With Benign Flora
|
Phase 1 | |
Terminated |
NCT03697993 -
Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)
|
Phase 4 | |
Terminated |
NCT01803919 -
Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients
|
N/A | |
Enrolling by invitation |
NCT01231737 -
Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)
|
Phase 2 | |
Completed |
NCT01763008 -
A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
|
Phase 4 |